Drug rash: Difference between revisions

(17 intermediate revisions by 4 users not shown)
Line 1: Line 1:
==Background==
==Background==
===ABCs of Drug Rashes===
===ABCs of Drug Rashes===
*'''A'''cute generalized exanthemous pustulosis (AGEP)
*'''A'''cute generalized exanthematous pustulosis ([[Acute generalized exanthematous pustulosis|AGEP]])
*'''B'''ullous disease, drug enduced
*'''B'''ullous disease, drug induced
*'''C'''aptopril (ACE-inhibitor) induced angioedema
*'''C'''aptopril ([[ACE-inhibitor]]) induced [[angioedema]]
*'''D'''rug reaction with eosinophilia and systemic symptoms (DRESS) syndrome
*'''D'''rug reaction with eosinophilia and systemic symptoms [[DRESS syndrome|(DRESS) syndrome]]
*'''S'''JS/TEN
*'''S'''JS/[[TEN]]
 
{{Rash red flags}}


==Clinical Features==
==Clinical Features==
*sudden, usus morbilliform, often starts on face & trunk & spreads
[[File:Drugreaction.jpg|300px|thumb|Morbilliform drug eruption on back]]
* Sudden, usually morbilliform, often starts on face & trunk & spreads
* More polymorphous than viral exanthem


==Differential Diagnosis==
==Differential Diagnosis==
{{Generalized rash DDX}}
{{Erythematous rash DDX}}
 
==Evaluation==
*Typically a clinical diagnosis
 
{{Table of severe drug reactions}}


==Management==
==Management==
* Discontinue offending agent
* Supportive
* [[Topical steroids]] may help relieve pruritus
==Disposition==
*If no signs of [[anaphylaxis]] or significant sloughing, consider outpatient management


==See Also==
==See Also==
*[[Rashes]]
*[[Erythematous rash]]
 
==External Links==
 
 
==References==
<references/>


[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Pharmacology]]
[[Category:Pharmacology]]

Revision as of 21:01, 10 September 2020

Background

ABCs of Drug Rashes

Rash Red Flags[1]

Clinical Features

Morbilliform drug eruption on back
  • Sudden, usually morbilliform, often starts on face & trunk & spreads
  • More polymorphous than viral exanthem

Differential Diagnosis

Erythematous rash

Evaluation

  • Typically a clinical diagnosis

Table of Severe Drug Rashes

Charateristic DRESS SJS/TEN AGEP Erythroderma
Image PMC3894017 JFMPC-2-83-g001.png Stevens-johnson-syndrome.jpg Acute generalized exanthematous pustulosis.png Red (burning) Skin Syndrome - Feet Collage.jpg
Onset of eruption 2-6 weeks 1-3 weeks 48 hours 1-3 weeks
Duration of eruption (weeks) Several 1-3 <1 Several
Fever +++ +++ +++ +++
Mucocutaneous features Facial edema, morbilliform eruption, pustules, exfoliative dermattiis, tense bullae, possible target lesions Bullae, atypical target lesions, mucocutaneous erosions Facial edema, pustules, tense bullae, possible target lesions, possibl emucosal involvement Erythematous plaques and edema affecting >90% of total skin surface with or without diffuse exfoliation
Lymph node enlargement +++ - + +
Neutrophils Elevated Decreased Very elevated Elevated
Eosinophils Very elevated No change Elevated Elevated
Atypical lymphocytes + - - +
Hepatitis +++ ++ ++ -
Other organ involvement Interstitial nephritis, pneumonitis, myocarditis, and thydoiditis Tubular nephritis and tracheobronical necrosis Possible Possible
Histological pattern of skin Perivascular lymphocytcic infiltrate Epidermal necrosis Subcorneal pustules Nonspecific, unless reflecting Sezary syndrome or other lymphoma
Lymph node histology Lymphoid hyperplasia - - No, unless reflecting Sezary syndrome or other malignancy
Mortality (%) 10 5-35 5 5-15

Management

  • Discontinue offending agent
  • Supportive
  • Topical steroids may help relieve pruritus

Disposition

  • If no signs of anaphylaxis or significant sloughing, consider outpatient management

See Also

External Links

References

  1. Nguyen T and Freedman J. Dermatologic Emergencies: Diagnosing and Managing Life-Threatening Rashes. Emergency Medicine Practice. September 2002 volume 4 no 9.